The role of 50 millesimal potency in management of benign prostatic hyperplasia: A review
Abstract
Benign Prostatic Hyperplasia (BPH) is a common condition clinical in aging male, which is characterized by an enlarged prostate gland that leads to lower urinary tract symptoms like difficulty in urination, burning and painful sensation during urination and Nocturia that significantly impact quality of life. Homoeopathic medicine, particularly in 50 millesimal potency is also called LM potency, offers a unique approach to the individualized management of BPH. Homoeopathic LM potency, known for its gentle and deep-acting nature, offers a promising alternative in managing BPH symptoms holistically. This review explores the therapeutic efficacy, safety, and underlying principles of using 50 millesimal potency remedies in managing BPH. By focusing on individualized remedies and the principle of minimum dose, this approach addresses both the symptoms and the underlying dynamic pathology of BPH. The review underscores the importance of individualization and miasmatic considerations in treatment This Review article aims to familiarize physicians with the clinical significance and Therapeutic use of 50 millesimal potency in Benign Prostatic Hyperplasia (BPH). This search strategy for this review article The Role of 50 Millesimal Potency in Management of Benign Prostatic Hyperplasia included all clinical trials, observational studies, and reviews published in previous years and the Homeopathic Materia Medica, homeopathic website, Indian Homeopathic Pharmacopoeia, and books such as…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.